NEXT Financial Group, Inc - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 33 filers reported holding CANCER GENETICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$02,5000.0%0.00%
Q2 2019$0
-100.0%
2,5000.0%0.00%
Q1 2019$1,0000.0%2,5000.0%0.00%
Q4 2018$1,000
-66.7%
2,5000.0%0.00%
-100.0%
Q3 2018$3,000
-57.1%
2,5000.0%0.00%
-50.0%
Q3 2017$7,000
-99.9%
2,5000.0%0.00%0.0%
Q2 2017$10,000,0000.0%2,5000.0%0.00%
-33.3%
Q1 2017$10,000,000
+233.3%
2,5000.0%0.00%
+200.0%
Q4 2016$3,000,000
+22976.9%
2,500
-66.7%
0.00%
-50.0%
Q3 2016$13,0007,5000.00%
Other shareholders
CANCER GENETICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 30,048$235,0003.84%
Millrace Asset Group, Inc. 198,774$1,554,0001.67%
EAM Investors, LLC 129,972$1,016,0000.16%
TURNER INVESTMENTS LLC 94,730$741,0000.15%
Granite Investment Partners, LLC 156,993$1,227,0000.12%
Sterneck Capital Management, LLC 20,030$157,0000.10%
DIKER MANAGEMENT LLC 28,815$225,0000.05%
ARDSLEY ADVISORY PARTNERS LP 15,000$117,0000.03%
VANGUARD GROUP INC 4,972,880$172,109,0000.01%
DENVER INVESTMENT ADVISORS LLC 14,141$111,0000.01%
View complete list of CANCER GENETICS INC shareholders